By Heidi Ledford
By looking for the genetic alterations that occur in tumour cells, a new assay could allow clinicians to use a simple blood test to track cancer during and after treatment.
The technique, developed by Victor Velculescu and Rebecca Leary at Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and their colleagues, generates patient-specific biomarkers using high-throughput DNA sequencing. [More]
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!